Added to YB: 2025-10-13
Pitch date: 2025-10-09
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+46.07%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$34.2B
Pitch Price
$66.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.35
P/E
48.27
EV/Sales
2.92
Sector
Pharmaceuticals
Category
value
Teva: Momentum building behind the neuroscience pipeline ($TEVA)
TEVA: Former generics giant now neuroscience growth story. Ajovy migraine therapy ~$70M quarterly, growing market share. Key catalyst: TEV-749 olanzapine LAI Phase 3 success, no PDSS cases in 3,500 injections, $1.5-2B peak sales potential. 2025: ~$17B revenue, $2.60 EPS, 27%+ EBIT margins. Net debt falling $18B→$11B. Trading 7x 2025 earnings despite branded pipeline momentum.
Read full article (3 min)